Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets (Unaudited)

v3.20.4
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
Dec. 31, 2020
Mar. 31, 2020
Current assets:    
Cash and cash equivalents $ 5,541,000 $ 3,691,000
Accounts receivable, net 4,408,000 4,062,000
Inventories, net 2,958,000 2,192,000
Prepaid expenses and other current assets 3,087,000 2,256,000
Current portion of deferred consideration, net of discount 218,000 182,000
Total current assets 16,212,000 12,383,000
Operating lease right-of-use assets 671,000 963,000
Property and equipment, net 404,000 365,000
Deferred consideration, net of discount, less current portion 829,000 786,000
Other assets 115,000 64,000
Total assets 18,231,000 14,561,000
Current liabilities:    
Accounts payable 2,430,000 2,086,000
Accrued expenses and other current liabilities 1,049,000 1,774,000
Deferred revenue 150,000 228,000
Deferred revenue Invekra 54,000 45,000
Operating lease liabilities 200,000 251,000
Current portion of long-term debt 0 481,000
Total current liabilities 3,883,000 4,865,000
Operating lease liabilities - non-current 471,000 746,000
Long-term deferred revenue Invekra 251,000 245,000
Long-term debt 1,310,000 0
Total liabilities 5,915,000 5,856,000
Stockholders' Equity    
Convertible preferred stock, $0.0001 par value; 714,286 shares authorized at December 31, 2020 and March 31, 2020, respectively, 0 and 1.55 shares issued and outstanding at December 31, 2020 and March 31, 2020, respectively 0 0
Common stock, $0.0001 par value; 24,000,000 shares authorized at December 31, 2020 and March 31, 2020, 2,079,059 and 1,777,483 shares issued and outstanding at December 31, 2020 and March 31, 2020, respectively 2,000 2,000
Additional paid-in capital 189,085,000 186,559,000
Accumulated deficit (172,536,000) (172,246,000)
Accumulated other comprehensive loss (4,235,000) (5,610,000)
Total stockholders' equity 12,316,000 8,705,000
Total liabilities and stockholders' equity $ 18,231,000 $ 14,561,000